This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Spanish to English: Practice Translation for MSc in Scientific Technical and Medical Translation General field: Medical
Source text - Spanish INTRODUCCIÓN
La astenia relacionada con el cáncer se define como “una sensación angustio- sa, persistente y subjetiva de cansancio o agotamiento relacionada con el cáncer o su tratamiento, que no es proporcional con la actividad realizada y que interfiere con las funciones habituales”(1). A diferencia de la astenia experimentada por un individuo sano, es más intensa, más angustiosa y no se alivia con el descanso.
Se trata de uno de los síntomas con ma- yor prevalencia en el paciente oncológico, de manera que el 95% de los pacientes que reciben quimioterapia y/o radioterapia presentan astenia en mayor o menor grado(2). Además, hasta en un 17%-30% de los supervivientes persiste durante me- ses o incluso años después de finalizar el tratamiento(3,4).
Por otra parte, la astenia se asocia a un detrimento en las actividades físicas, psicológicas y sociales, lo que impacta desfavorablemente en la calidad de vida. Su influencia sobre este aspecto es mayor que la de otros síntomas, como las náuseas, el dolor o la depresión(2).
En un estudio acerca de la percepción de la astenia en pacientes con cáncer en España, un 97,8% de los pacientes refería haber experimentado astenia a lo largo del tratamiento oncológico, lo que afectaba notablemente su estado de ánimo. Ade- más, la astenia era considerada el síntoma más limitante para la mayoría de los pacientes, independientemente del sexo o del tipo de tumor (5).
Translation - English INTRODUCTION
Cancer-related fatigue is defined as “a distressing, persistent, subjective sense of fatigue or exhaustion related to cancer or its treatment, that is not proportional to recent activity and interferes with usual functioning”(1). Unlike fatigue experienced by a healthy individual, it is more intense, more distressing and is not alleviated by rest.
It is one of the symptoms with higher prevalence in oncology patients, and 95% of patients who receive chemotherapy and/or radiation therapy present with fatigue to a greater or lesser degree(2). In addition, in 17%-30% of survivors, fatigue continues for months or even years after the treatment ends(3,4).
On the other hand, fatigue is associated with a lack in physical, psychological and social activities, which adversely affects the quality of life. This influence is greater than that of other symptoms, such as nausea, pain or depression(2).
In a study about the perception of fatigue in patients with cancer in Spain, 97.8% of patients reported having experienced fatigue throughout oncology treatment, which significantly affected their mood. In addition, fatigue was considered the most limiting symptom for most patients, regardless of gender or the type of tumour (5).
More
Less
Translation education
Master's degree - University College London
Experience
Years of experience: 11. Registered at ProZ.com: Jan 2014.
Spanish to English (University College London) Japanese to English (University of Birmingham) Spanish to English (Institute of Translation and Interpreting)
I am particularly interested in medical translation and have over 5 years experience translating a wide range of medical texts from Informed Consent Forms (ICFs) to medical correspondence and discharge notes.
I am a UCL graduate with an MSc in Scientific, Technical and Medical Translation with Translation Technology. I completed my dissertation by translating an article about revolutionary surgery for breast reconstruction using platelet rich plasma gel.
Expertise